082270 Stock Chart & Stats
₩10120.00
-₩810.00(-7.41%)
―
--
Day’s Range― - ―
52-Week Range₩8,980.00 - ₩61,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)240.03K
Market Cap
₩444.82B
Enterprise Value₩583.44K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-224.44
Shares Outstanding44,269,203
10 Day Avg. Volume165,755
30 Day Avg. Volume240,029
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
082270 FAQ
What was GemVax & KAEL Co Ltd’s price range in the past 12 months?
GemVax & KAEL Co Ltd lowest stock price was ₩8980.00 and its highest was ₩61000.00 in the past 12 months.
What is GemVax & KAEL Co Ltd’s market cap?
GemVax & KAEL Co Ltd’s market cap is ₩444.82B.
When is GemVax & KAEL Co Ltd’s upcoming earnings report date?
GemVax & KAEL Co Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 79 days.
How were GemVax & KAEL Co Ltd’s earnings last quarter?
GemVax & KAEL Co Ltd released its earnings results on Aug 14, 2026. The company reported -₩224.44 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is GemVax & KAEL Co Ltd overvalued?
According to Wall Street analysts GemVax & KAEL Co Ltd’s price is currently Undervalued.
Does GemVax & KAEL Co Ltd pay dividends?
GemVax & KAEL Co Ltd does not currently pay dividends.
What is GemVax & KAEL Co Ltd’s EPS estimate?
GemVax & KAEL Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GemVax & KAEL Co Ltd have?
GemVax & KAEL Co Ltd has 44,269,203 shares outstanding.
What happened to GemVax & KAEL Co Ltd’s price movement after its last earnings report?
GemVax & KAEL Co Ltd reported an EPS of -₩224.44 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.078%.
Which hedge fund is a major shareholder of GemVax & KAEL Co Ltd?
Currently, no hedge funds are holding shares in KR:082270
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dong-A ST Co., Ltd.
―
AbClon, Inc.
―
Curocell, Inc.
―
G2GBIO, Inc.
―
Onconic Therapeutics, Inc.
―